ABTA

New Statistical Report Reveals Primary Brain and Central Nervous System Tumors as Second Most Common Cancer Type in Adolescents and Young Adults

Retrieved on: 
Tuesday, May 7, 2024
CONNECT, Neuro-Oncology (journal), Brain, Adolescence, Bangladesh Technical Education Board, Survival, AYA, Partnership, National Cancer Institute, Research, History, CNS, Young adult, Disease, American Brain Tumor Association, Patient, Neurosurgery, NCI, ABTA, Neoplasm, Central nervous system, Biology, Clinical trial, Prevalence, Medical imaging

CHICAGO, May 7, 2024 /PRNewswire/ -- Today, the American Brain Tumor Association (ABTA), in partnership with the National Institutes of Health's National Cancer Institute (NCI) Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) program and the Central Brain Tumor Registry of the United States (CBTRUS), unveiled a new report shedding light on the prevalence of primary brain and other central nervous system (CNS) tumors among adolescents and young adults (AYAs) between the ages of 15 and 39. The report, Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States, 2016–2020, published in Neuro-Oncology, aims to increase awareness of and insight into an underserved population with unique needs distinct from pediatric and older adult patient populations. 

Key Points: 
  • While cancer survival has been improving overall, adolescents and young adults between the ages of 15 and 39 have not experienced these same increases in survival.
  • The researchers found primary brain and other CNS tumors are the second most common cancer type in AYAs, with an average of 12,848 individuals diagnosed annually.
  • Over 90 percent survived for at least five years, with approximately 208,620 AYAs living with a history of brain or other CNS tumor diagnosis in 2024.
  • The ABTA is committed to ensuring the AYA brain tumor community has access to customized educational and emotional support resources to meet their unique needs.

American Brain Tumor Association Announces New Board of Directors Officers and Members

Retrieved on: 
Tuesday, February 27, 2024
International law, Prostate cancer, Candel, Cancer, Hospital, IPO, Doctor of Philosophy, Partner, Therapy, Texas Children's Hospital, Patient, ABTA, Baylor College of Medicine, American Brain Tumor Association, Harvard Medical School, Brain, Research, Boston Children's Hospital

CHICAGO, Feb. 27, 2024 /PRNewswire/ -- The American Brain Tumor Association announced today the appointment of officers and new members to serve as the Board of Directors.

Key Points: 
  • CHICAGO, Feb. 27, 2024 /PRNewswire/ -- The American Brain Tumor Association announced today the appointment of officers and new members to serve as the Board of Directors.
  • They will advance the ABTA mission under the leadership of Ram Subramanian, Board Chair, and Ralph DeVitto, President and CEO.
  • "Over the past year, the American Brain Tumor Association has experienced tremendous growth, demonstrating the impact of our board's vision and commitment," DeVitto said.
  • The 2024 ABTA Board of Directors Officers and Members:

American Brain Tumor Association Announces $1.3 Million in New Funding to Accelerate Adult and Pediatric Brain Tumor Research

Retrieved on: 
Wednesday, November 8, 2023
Soma, American Brain Tumor Association, Biomarker, Neuro, History, MD, Soma Sengupta, ABTA, Research, Chapel Hill, Mount Sinai, Brain, DNA repair, Icahn School of Medicine at Mount Sinai, Patient, Doctor of Philosophy, Joel, DNA, Medical imaging, Pharmaceutical industry, Citrus

CHICAGO, Nov. 8, 2023 /PRNewswire/ -- The American Brain Tumor Association (ABTA) today announced the funding of $1.37 million towards 23 new research grants to advance brain tumor science and treatments, across all brain tumor types and ages. Dedicated to advancing the field of neuro-oncology and accelerating the discovery of life-saving treatments, the ABTA is proud to have invested more than $35 million, to approximately 700 researchers and 800 projects, to date.

Key Points: 
  • CHICAGO, Nov. 8, 2023 /PRNewswire/ -- The American Brain Tumor Association (ABTA) today announced the funding of $1.37 million towards 23 new research grants to advance brain tumor science and treatments, across all brain tumor types and ages.
  • ABTA's high-risk, high-reward research grants have contributed to significant breakthroughs in treating brain tumors.
  • This year's slate of research projects investigates biomarkers, DNA damage and repair mechanisms, gene therapies, and more, across adult and pediatric primary brain tumors and metastatic brain cancers.
  • Research Collaboration Grants are two-year, $200,000 grants awarded for multi-investigator and multi-institutional brain tumor collaborative research projects.

neuro42 Announces Participation at the 2023 American Brain Tumor Association National Conference

Retrieved on: 
Tuesday, September 5, 2023
American Brain Tumor Association, National Conference, ABTA, MRI, Neurosurgery, SAN, Robotics, Conference, Medical imaging

SAN FRANCISCO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- neuro42, Inc. (“neuro42” or the “Company”), a medical technology Company leading the next evolution of MRI and robotics, today announced that neuro42 will participate at the 2023 American Brain Tumor Association (ABTA) National Conference in Chicago, IL on September 8-9, 2023.

Key Points: 
  • SAN FRANCISCO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- neuro42, Inc. (“neuro42” or the “Company”), a medical technology Company leading the next evolution of MRI and robotics, today announced that neuro42 will participate at the 2023 American Brain Tumor Association (ABTA) National Conference in Chicago, IL on September 8-9, 2023.
  • “We are thrilled to join the ABTA community at its annual conference, demonstrating neuro42 leadership in MRI intervention and robotics for neurosurgery,” said Abhita Batra, Founder and Chief Strategy Officer of neuro42.
  • “neuro42 is in active development of its MRI technology platform to effectively guide brain tumor interventional procedures and treatment, addressing the needs of an estimated 80 thousand brain tumor cases detected in the US annually.”
    neuro42 will participate in the Corporate Recognition and Networking Dinner on September 7 between 6:30pm - 8:30pm at the Moretti’s restaurant in Rosemont, IL.
  • neuro42 is also hosting an exhibit showcasing its portable neuro imaging system under development at booth #31 at ABTA 2023.

American Brain Tumor Association Announces $50-Million Fundraising Campaign to Accelerate Research, Improve Lives of Brain Tumor Patients

Retrieved on: 
Tuesday, August 22, 2023
Linda, Brain, Prevalence, Education, American Brain Tumor Association, National Conference, Hope, Research, History, Mother, ABTA, Incidence, Patient, Diagnosis, Neuro, Family, Conference, Mobile phone, Medical imaging

CHICAGO, Aug. 22, 2023 /PRNewswire/ -- A champion of the brain tumor community for 50 years running, the American Brain Tumor Association (ABTA) has launched its most ambitious undertaking yet – a five-year, $50-million fundraising campaign called Meet Hope Head On.

Key Points: 
  • ABTA Commemorates 50th Anniversary at 2023 National Conference, September 8-9
    CHICAGO, Aug. 22, 2023 /PRNewswire/ -- A champion of the brain tumor community for 50 years running, the American Brain Tumor Association (ABTA) has launched its most ambitious undertaking yet – a five-year, $50-million fundraising campaign called Meet Hope Head On.
  • The Meet Hope Head On campaign will focus on three pillars: tripling the ABTA's research investment, doubling the number of patients served, and doubling federal funding for brain tumor research.
  • The Meet Hope Head On campaign accelerates our vision of a future where not one life – not one loved one – is lost to a brain tumor."
  • At the time of ABTA's founding, brain tumor resources were limited and neuro-oncology as a medical specialty did not exist.

SonALAsense Announces Completion of First Cohort in Phase 2 Study of SONALA-001 Sonodynamic Therapy for Recurrent Glioblastoma

Retrieved on: 
Wednesday, March 8, 2023
Biotechnology, Health, Radiology, Pharmaceutical, Oncology, Health Technology, Medical Devices, Research, Surgery, Science, Clinical Trials, ALA, NYU, Learning, High-intensity focused ultrasound, Brain, Cell death, Light, Patient, Sonodynamic therapy, ABTA, American Brain Tumor Association, Cleveland Clinic, University of California, San Francisco, Mayo Clinic, Clinical trial, Radiation, Monroe Dunaway Anderson, Decompression (diving), Oxidative stress, Quality of life, Barrow Neurological Institute, Glioblastoma, SDT, POC, University, Aminolevulinic acid, Doctor of Philosophy, Cleveland, Safety, Medical imaging, Medical device, MD

SDT-202 is an open-label, dose-escalation trial of SDT in recurrent glioblastoma (rGBM).

Key Points: 
  • SDT-202 is an open-label, dose-escalation trial of SDT in recurrent glioblastoma (rGBM).
  • The first cohort in SDT-202 was enrolled at Cleveland Clinic by principal investigator Matthew Grabowski, MD.
  • “At SonALAsense, we are excited to further develop SONALA-001 SDT as a potential approach to treat this devastating brain cancer.
  • “We look forward to the outcomes of this clinical trial and learning more about the potential benefits of sonodynamic therapy.”

American Brain Tumor Association Announces New Board of Directors Chair, Officers and Member

Retrieved on: 
Tuesday, February 21, 2023
Ram, American Brain Tumor Association, Andersen, Brain, Diagnosis, Patient, Friends, CFA, Research, Family, Chairperson, Torrey DeVitto, PNC Financial Services, Discover Financial, ABTA, Medical imaging

CHICAGO, Feb. 21, 2023 /PRNewswire/ -- The American Brain Tumor Association announced today the appointment of Ram Subramanian as Chair of the Board of Directors, and newly-elected Member Srisupen Andersen, CFA.

Key Points: 
  • CHICAGO, Feb. 21, 2023 /PRNewswire/ -- The American Brain Tumor Association announced today the appointment of Ram Subramanian as Chair of the Board of Directors, and newly-elected Member Srisupen Andersen, CFA.
  • In his new role as Board Chair, Ram Subramanian is responsible for leading the ABTA's Board of Directors, which provides strategic governance for the organization.
  • Impacted by the brain tumor diagnosis of close friends and family, Subramanian is dedicated to ensuring brain tumor families have access to information and support they need to navigate a brain tumor diagnosis.
  • The 2023 American Brain Tumor Association Board of Directors:
    Ram Subramanian—Chair; Bob Kruchten—Vice Chair; Danny Monson—Treasurer; Mindee Plugues—Secretary; Carla Varner—Immediate Past Chair; and Members—Srisupen Andersen; Mitchel S. Berger, M.D.

Travel Industry Urged to Prove Commitment to Sustainability

Retrieved on: 
Tuesday, November 8, 2022
GLOBE, Partnership, Air travel, Awareness, Travel, Intrepid, Intrepid Travel, Nature, ABTA, Industry, Tourism

Inspiring Vacations says in response, many travel brands are moving to confront the issue and a growing niche industry is emerging that prioritises sustainability.

Key Points: 
  • Inspiring Vacations says in response, many travel brands are moving to confront the issue and a growing niche industry is emerging that prioritises sustainability.
  • Recently, the company urged delegates at the Abta travel convention in Morocco to take industry action now.
  • With consumers more concerned about sustainability than ever, the travel industry needs to consider how it can improve customer experiences and make sure it is demonstrating how it is making an impact to address concerns.
  • To discover sustainable travel options including tours to Egypt and tours to Cape York, contact Inspiring Vacations.

American Brain Tumor Association Awards 20 Research Grants to Advance Brain Tumor Science and Discoveries

Retrieved on: 
Wednesday, November 9, 2022
Translational Genomics Research Institute, Association, Patient, Biomarker, MD, Doctor of Philosophy, American Brain Tumor Association, Immunotherapy, ABTA, Genetics, Caregiver, Neuro, Research, Brain, Multimedia, Adult, Medical imaging

CHICAGO, Nov. 9, 2022 /PRNewswire/ -- The American Brain Tumor Association (ABTA) today announced the funding of $821,000 towards 20 new research grants to advance brain tumor science and treatments.

Key Points: 
  • CHICAGO, Nov. 9, 2022 /PRNewswire/ -- The American Brain Tumor Association (ABTA) today announced the funding of $821,000 towards 20 new research grants to advance brain tumor science and treatments.
  • With more than $34 million invested in research to date, across all brain tumor types and ages, the ABTA research program plays a critical role in advancing the understanding of brain tumors and building the next generation of brain tumor researchers.
  • Floris Barthel, MD, The Translational Genomics Research Institute, Arizona
    Medical Student Summer Fellowshipsare three-month, $3,000 grants awarded to medical students to conduct brain tumor research projects under the guidance of neuro-oncology experts.
  • Founded in 1973, the American Brain Tumor Association provides comprehensive resources to support the complex needs of brain tumor patients and caregivers, across all ages and tumor types, as well as the critical funding of research in pursuit of breakthroughs in brain tumor diagnoses, treatments, and care.

Sail Croatia Continues to Work With Family-Owned & Operated Ships

Retrieved on: 
Tuesday, October 18, 2022
Education, Health, ABTA, Friends, Company, Captain, Industry, Nature, National Safety Council of Australia, Privateer Yacht Club, Radar, British Safety Council, Safety, Cruise, Tourism, Cruise line, Adriatic Sea, IOSH, Travel

Established in 2005, Sail Croatia is a globally focused, UK-based business providing luxury small ship cruises, party cruises, active cruises, and yacht experiences along the Dalmatian coast of Croatia.

Key Points: 
  • Established in 2005, Sail Croatia is a globally focused, UK-based business providing luxury small ship cruises, party cruises, active cruises, and yacht experiences along the Dalmatian coast of Croatia.
  • The Company continues to work with family-owned and operated ships, after working tirelessly over the years to build these valuable local connections.
  • If youre looking for a more active way to explore beautiful Croatia, then choose Sail Croatias Cycle or Hike Cruise.
  • To find out more about Sail Croatia and to see a full list of their small ship cruises, please visit their website at https://www.sail-croatia.com/ .